Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.098 | 0.7 |